Image Credit: Canva
Stress is an inevitable part of life, but its consequences are not just mood swings and mental fatigue. Continual stress makes people produce extra cortisol, a hormone that has a critical role in adapting to short-term challenges, but chronically in high quantities it tends to cause harm to the body causing lots of physical and mental disorders.
The adrenal glands produce cortisol, which helps the body control its "fight, flight, or freeze" response. Cortisol temporarily adjusts blood sugar levels, maintains blood pressure, and assists the immune system, among other functions, in short spurts. But when stress persists, cortisol remains high, and necessary functions of the body are interfered with and rendered more susceptible to disease.
According to one survey conducted by the American Psychological Association, stress negatively affects a third of Americans' physical health. Concerns are reinforced by research where studies have shown 80% of primary care visits are stress-related.
But why does stress have such a profound impact? Elevated cortisol limits the immune system's ability to fight infections, disrupts hormonal balance, and triggers inflammation. Over time, these changes can lead to serious health complications.
Do you have involuntary eye spasms? These harmless but annoying twitches often indicate elevated cortisol. The tiny muscles around the eyes are extremely sensitive to stress, contracting or spasming because of cortisol's stimulant-like effects.
Your skin often reflects what is going on inside your body, and chronic stress can cause inflammatory skin conditions. Elevated cortisol levels stimulate oil production, which exacerbates acne. It also slows down the healing process, worsens conditions like eczema, and contributes to general irritation of the skin.
It also interferes with the body's balance of salt and water, which causes fluid retention and bloating. Excess cortisol also slows down blood flow to the digestive system, which further weakens gut bacteria and causes poor digestion, excess gas, and abdominal discomfort.
High cortisol stimulates the production of insulin, which can cause blood sugar to drop, making people want to eat sugary, high-fat foods. For many, this becomes an excuse to stress-eat and gain weight. For others, the opposite is true: their appetite disappears under stress, causing them to lose weight.
If you’re noticing random bruises, elevated cortisol could be the culprit. This hormone weakens skin proteins and the walls of small blood vessels, making your skin more fragile and prone to damage.
Do you feel rundown or experience muscle aches, fatigue, or upset stomach regularly? Elevated cortisol mimics cold-like symptoms. Long-term stress also weakens the immune system, making you more susceptible to infections.
Also Read: Stressed At Work? Your Sleep Might Be Paying The Price, New Study Shows
Chronic stress can damage your eyesight. Elevated cortisol disrupts blood flow to the eyes, increases eye pressure, and raises the risk of glaucoma. Symptoms like dry eyes, blurred vision, and light sensitivity are also common.
Irregular Menstrual Cycles that disrupt the menstrual period. In females, this leads to hormonal distress causing irregular or missed periods. Over time, it may also disturb fertility.
If you hear ringing, buzzing, or hissing sounds without an apparent source, stress might be the culprit. Cortisol affects the auditory system by interfering with blood flow and nerve function and could be the trigger for tinnitus.
Increased levels of cortisol contribute to inflammation that can exacerbate conditions such as arthritis and promote the development of heart disease. Chronic inflammation is also associated with mental health conditions, including anxiety and depression.
Left unchecked, high cortisol levels can lead to more than just short-term discomfort. Chronic stress has been associated with serious conditions such as heart disease, psychiatric disorders, and metabolic syndromes. A 2013 study published in JAMA Internal Medicine underlined the link between stress and physical health, with recent research in Neurobiology of Stres supporting these findings.
Managing stress and cortisol levels is essential for maintaining overall health. One effective approach is practicing mindfulness through meditation or yoga, which helps lower cortisol by calming the mind and promoting relaxation. Regular physical exercise, especially aerobic activities, helps reduce stress hormones and boosts endorphins. Prioritizing sleep is crucial, as lack of rest can increase cortisol levels; aim for 7-9 hours per night.
Another remedy is an overall balanced diet full of anti-inflammatory foods like fruits, vegetables, and whole grains that could manage cortisol production. Finally, it would prevent burnout and chronic stress if proper boundaries were set at work and in personal life.
Credit: AI image
As Delhi wakes up to another spell of deteriorating air quality just days ahead of Diwali, ophthalmologists warn that dust, smoke, particulate matter, and toxic gases can affect children's eyes, triggering redness, itching, burning, excessive watering, and dryness.
On Tuesday, India's national capital's average Air Quality Index (AQI) climbed to 331 at 7 am, entering the ‘very poor’ category. At the same time, eight monitoring stations recorded readings above 400, falling in the ‘severe’ zone, according to the Central Pollution Control Board (CPCB).
As per data from the CPCB, 33 of the city's 58 monitoring stations recorded AQI levels in the ‘very poor’ category. Meanwhile, the India Meteorological Department (IMD) and the Indian Institute of Tropical Meteorology have forecast that air quality is likely to remain in the ‘very poor’ category over the coming days.
“Children’s eyes are more sensitive to irritants in the environment, and exposure to pollutants, particulate matter and toxic gases can irritate the surface of the eye,” Dr Shibal Bhartiya, Clinical Director – Ophthalmology and Program Director – Community Outreach and Wellness at Marengo Asia International Institute of Neuro and Spine (MAIINS), told HealthandMe.
The experts warned that exposure to pollutants and particulate matter can irritate the surface of children's eyes, causing redness, itching, burning, excessive tearing and dryness.
Dr Neepa Thacker Dave, Senior Consultant in Paediatric Ophthalmology at SRCC Children's Hospital, told HealthandMe that the eye’s surface is protected by a delicate tear film that provides lubrication, maintains clear vision and helps defend against environmental irritants. Exposure to airborne pollutants can disturb this protective layer and contribute to ocular surface irritation and inflammation.
"Excessive watering does not necessarily mean that the eyes are adequately lubricated. Irritation can trigger reflex tearing even when the tear film is unstable. Consequently, children may experience watering alongside dryness or discomfort," she said.
Further, children with existing allergies or sensitive eyes may notice their symptoms worsening during periods of high pollution.
“Long-term exposure to poor air quality may also worsen pre-existing ocular surface conditions,” Dr Bhartiya said.
Read More: Rising AQI In Delhi-NCR: Doctors Warn Of Lung And Heart Risks As Pollution Builds
Reducing children's exposure to pollution is important, particularly on days when air quality is poor.
Dr Bhartiya advised parents to:
Dr Dave also highlighted the importance of greater awareness, reduced exposure and timely medical care in protecting children from pollution-related eye irritation and discomfort.
Dr Dave said children may not always have the vocabulary to describe eye discomfort. Parents and teachers should watch for frequent eye rubbing, excessive blinking, squinting, watering or reluctance to participate in reading and outdoor activities.
Parents should not dismiss eye irritation in children, particularly when pollution levels are high.
Although mild irritation may improve when exposure is reduced, recurring or persistent symptoms warrant an eye examination. Eye pain, significant sensitivity to light, blurred or reduced vision, marked redness or difficulty opening the eye require prompt medical attention.
Credit: iStock
Type 2 diabetes is an incurable but manageable metabolic disorder that affects millions worldwide. But a new clinical trial has shown promise in reversing type 2 diabetes in young adults through intensive diet and exercise. It suggests that more than half younger adults with this condition may be able to achieve remission within six months through a structured programme combining a low-calorie diet with supervised aerobic and strength training.
The study, published in The Lancet Regional Health – Americas, found that 54% of participants who followed the intensive lifestyle programme achieved diabetes remission after 24 weeks. In comparison, only 4% of those receiving usual medical care reached the same outcome.
The research, called the RESET for Remission trial, was led by researchers from McGill University in Canada and the University of Leicester in the UK. It focused on adults with early-onset type 2 diabetes, a form of the disease diagnosed before the age of 45.
Also read: GLP-1 Drugs May Be More Effective Than Metformin At Preventing Diabetes: Study
The trial enrolled 96 adults aged 18 to 45 who had both obesity and type 2 diabetes. Participants were recruited at research centres in Montreal and Edmonton in Canada, and Leicester in the UK. None of them were using insulin.
Of these, 50 were assigned to the intensive diet-and-exercise programme, while 46 received usual medical care. For the first 12 weeks, participants in the intervention group followed a very low-calorie diet providing 800 to 900 calories a day.
During the first two weeks, they consumed meal-replacement products. From weeks three to 12, they could include one structured meal containing lean protein and vegetables alongside the meal replacements.
The programme also included supervised aerobic and resistance training twice a week, along with one independent exercise session each week. For the next 12 weeks, participants followed a healthy diet designed to maintain their weight loss and continued exercising.
Blood sugar and blood pressure medications were stopped at the beginning of the intervention under medical supervision, according to the study protocol.
To qualify for remission, participants had to maintain an HbA1c level below 6.5% without taking medication for at least 12 weeks. HbA1c is a blood test that reflects average blood sugar levels over approximately three months.
Also read: Early Adulthood Obesity Linked To Thyroid, Ovarian And Endometrial Cancers: Study Of 6.3 Million
At the end of 24 weeks, 27 of the 50 participants in the intensive lifestyle group had achieved remission, compared to two of the 46 participants receiving usual care.
After considering relevant factors, researchers found that participants following the intensive programme were 21 times more likely to achieve remission than those receiving standard care.
The intervention group also experienced greater weight loss. Participants with available weight data lost an average of 8.4 kg over 24 weeks, compared to 1.2 kg in the usual care group. After adjustment, the difference in weight loss between the groups was approximately 7.5 kg.
The benefits were not just limited to body weight and blood sugar. MRI scans showed that participants in the intervention group lost more than 9% of their liver fat and more than 24% of their visceral fat, which is the fat stored around internal organs.
Their physical fitness improved, grip strength increased, and blood pressure and resting heart rate declined. Participants also reported fewer symptoms of depressed mood, distress and better quality of life.
One of the important aspects of the programme was its focus on preserving muscle during rapid weight loss. Losing weight through severe calorie restriction can reduce both body fat as well as mass, which includes muscle. Researchers wanted to determine whether adding resistance training could help participants lose fat while maintaining muscle.
Lead author Dr Kaberi Dasgupta, professor of medicine and director of the Division of General Internal Medicine at McGill University, told Fox News Digital, "Our study shows that it is possible to combine a low-calorie diet with supervised exercise in young adults with type 2 diabetes," she said.
"There has previously been some concern about combining the two as being too much of a burden for people. However, people in our study stayed in our study."
Explaining the role of exercise in the results, Dasgupta said, "In our study, we think the diet provoked the weight loss, and exercise helped make sure it was [not] from muscle."
She added, "We were happy and surprised that not only did people lose fat from their organs and liver, our MRI studies indicated their muscle did not decrease at all and their handgrip strength went up."
The researchers also focused on muscle preservation. "Our findings demonstrate the feasibility and efficacy of combining structured aerobic and resistance exercise with a low energy diet in early onset type 2 diabetes, supporting its potential to deliver substantial and holistic health and well-being benefits alongside diabetes remission."
However, the trial did not include a separate group following the low-calorie diet without exercise. Therefore, researchers could not establish how much of the muscle preservation and fitness improvement was specifically due to exercise.
Dasgupta acknowledged this limitation and said, "The main limitation is that we had to compare the diet plus exercise with usual care," she said. "We would have liked to compare diet alone against diet and exercise to perfectly prove the point that the improvements in muscle and fitness were from the exercise."
Credit: AI
Metformin has been long used to manage diabetes. But a major analysis based on more than 256,000 adults with obesity and prediabetes has found that people who take GLP-1 medications like Ozempic and Mounjaro were less likely to develop type 2 diabetes than those taking metformin.
The study also found that people taking GLP-1 medications were more likely to return to normal blood sugar levels and had lower risks of heart attacks, strokes, heart failure and death from any cause compared to those taking metformin.
The findings come from preliminary research presented at the American Heart Association's (AHA) Scientific Sessions 2026. Researchers compared health records of adults to both obesity and prediabetes to examine whether GLP-1 medications could help prevent the progression to type 2 diabetes.
According to the AHA, the analysis included 256,492 adults, with an average age of 52 years. Women accounted for 76% of the participants.
About half of the participants were taking GLP-1-based medications, including semaglutide, tirzepatide, liraglutide and dulaglutide, while the remaining participants were taking metformin.
Researchers used electronic health records from the TriNetX global multicentre network, which included 104 institutions. The records covered the period from 2010 to 2023. The participants were followed for an average of approximately three years.
The researchers matched participants based on factors such as age, existing health conditions, including high blood pressure and sleep apnoea, nicotine dependence and other medications.
Also read: ‘Godzilla’ Drug Retatrutide Reverses Sleep Apnea In 1 In 4 Diabetes Patients
Compared to people on metformin, those taking GLP-1 medications had a 31% lower risk of developing type 2 diabetes.
They were also 1.5 times more likely to return to normal blood sugar levels, suggesting that the medications may help reverse the progression from prediabetes in some people.
The analysis also identified differences in cardiovascular results. Compared to the metformin group, people taking GLP-1 medications had:
The risk of death from any cause was also 41% lower among people taking GLP-1 medications.
Most earlier research on GLP-1 medications has focused on people who already have type 2 diabetes. This analysis examined their benefits at an earlier stage, when blood sugar levels are higher than normal but have enough for a diabetes diagnosis.
Commenting on the findings, study author Vinicius de Sousa Barzon Serra, MD, a research fellow in the Department of Cardiovascular Medicine at Mayo Clinic in Scottsdale, Arizona, said, “The great news with prediabetes is that it’s still possible to reverse the progression of the disease.”
He added, “This research may add to the case for considering GLP-1 medications earlier for certain patients, rather than waiting until they develop Type 2 diabetes.”
However, Serra said the findings do not mean metformin should be replaced by GLP-1 medications.
“The main effect these findings could have is on the shared decision-making discussion between doctors and patients exploring various treatment options, and the pros and cons for each,” he said.
“Metformin is still a first-line treatment choice. It is safe, inexpensive and has a long track record. This is less about replacing one medication with another and more about discussing additional options with specific patients,” he added.
Serra also highlighted the importance of lifestyle changes in preventing diabetes.
“It's important to note that an essential component of prediabetes treatment is lifestyle changes to manage weight, including diet and exercise and considering medications, including metformin, based on each individual's overall health and any other medical conditions,” he said.
Robert Eckel, MD, FAHA, a former volunteer president of the American Heart Association and professor of medicine emeritus at the University of Colorado Anschutz Medical Campus, said the findings were not surprising. “The benefits noted in this study likely relates to the patients losing weight, which is known to help prevent Type 2 diabetes,” said Eckel.
He explained that preventing the progression from prediabetes to type 2 diabetes could also help reduce cardiovascular complications.
“Preventing the progression from pre-diabetes to Type 2 diabetes keeps patients from having Type 2 diabetes, and it also helps prevent heart attack and strokes,” he said.
Eckel added, “GLP-1s provide another option for prevention, perhaps as an add-on therapy. However, costs and access to these medications are important factors.”
The findings should not be interpreted as evidence that Ozempic or Mounjaro is superior to metformin for every person with prediabetes.
The American Diabetes Association's 2026 Standards of Care identify metformin as an option for people at particularly high risk of developing type 2 diabetes, including adults aged 25 to 59 years with a BMI of 35 or higher, higher blood glucose levels or a history of gestational diabetes.
The guidelines also say that metformin has the most robust evidence for pharmacological diabetes prevention. While GLP-1-based therapies can be considered for weight management in people with overweight or obesity, long-term evidence does not currently support using glucose-lowering medications other than metformin solely for the purpose of preventing type 2 diabetes.
© $2026 Times Horizon Private Limited